Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.06
+0.22 (0.89%)
Jun 18, 2026, 10:02 AM EDT - Market open
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.39 billion as of June 18, 2026. Its market cap has increased by 161.72% in one year.
Market Cap
1.39B
Enterprise Value
1.08B
1-Year Change
161.72%
Ranking
Category
Stock Price
$25.06
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.39B, an increase of 102.41%. That is a compound annual growth rate of 67.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.32B | -33.76% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.41B |
| SELLAS Life Sciences Group | 1.40B |
| Ardelyx | 1.40B |
| MoonLake Immunotherapeutics | 1.40B |
| GH Research | 1.37B |
| Inhibrx Biosciences | 1.37B |
| Savara | 1.34B |
| Maravai LifeSciences Holdings | 1.29B |